Sign in

CIK 0001439725

  • Non-accelerated filer
  • Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203986492
Phone
+1 303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
Open-market buys, last 90 days
$1,001,990
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,001,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SCHULER JACK W +$1.0M 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-01-02 Strobeck Matthew Director Grant or award · Restricted Stock Units +6,804 6,804
2026-01-02 Strobeck Matthew Director Grant or award · Stock Options (Right to Buy) +6,354 6,354
2025-05-20 Strobeck Matthew Director Grant or award · Restricted Stock Units +80,525 80,525
2025-05-20 Strobeck Matthew Director Grant or award · Stock Options (Right to Buy) +42,010 42,010
2024-11-05 Strobeck Matthew Director Purchase +4,000 $1.40 $6K 89,673
2024-11-05 Strobeck Matthew Director Purchase +36,000 $1.40 $50K 2,606,879
2024-05-23 Strobeck Matthew Director Exercise or conversion +52,160 85,673
2024-05-23 Strobeck Matthew Director Exercise or conversion +295,680 2,570,879
2024-05-23 Strobeck Matthew Director Exercise or conversion · Series A Non-Voting Convertible Preferred Stock −1,304 0
2024-05-23 Strobeck Matthew Director Exercise or conversion · Series A Non-Voting Convertible Preferred Stock −7,392 0
2024-05-21 Strobeck Matthew Director Grant or award · Restricted Stock Units +53,726 53,726
2024-05-21 Strobeck Matthew Director Grant or award · Stock Options (Right to Buy) +37,050 37,050
2024-04-05 Strobeck Matthew Director Grant or award · Series A Non-Voting Convertible Preferred Stock +1,304 $46.00 $60K 1,304
2024-04-05 Strobeck Matthew Director Grant or award · Series A Non-Voting Convertible Preferred Stock +7,392 $46.00 $340K 7,392
2024-01-01 Strobeck Matthew Director Grant or award · Restricted Stock Units +105,389 140,036
2023-08-03 Strobeck Matthew Director Grant or award +127,777 $1.62 $207K 2,542,928
2023-08-03 Strobeck Matthew Director Grant or award +6,790 $1.62 $11K 119,003
2023-08-03 Strobeck Matthew Director Grant or award +6,790 $1.62 $11K 119,003
2023-08-03 Strobeck Matthew Director Grant or award +6,790 $1.62 $11K 119,003
2023-08-03 Strobeck Matthew Director Grant or award +6,790 $1.62 $11K 119,003

Page 1 of 2 · 39 trades